A double blind randomized study of the treatment of endometriosis with nafarelin or nafarelin plus norethisterone

Gynecological Endocrinology

Volumn 11, Issue 3, 1997, Pages 187-194

  Bergqvist, A ^a   Jacobson, J ^b   Harris, S ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Sodertalje Hospital   (Sweden)

^c Syntex Research Europe   (United Kingdom)

Author keywords

Add back therapy; Endometriosis; GnRH agonists; Low dose therapy

Indexed keywords

ESTRADIOL; NAFARELIN; NORETHISTERONE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENDOMETRIOSIS; ESTRADIOL BLOOD LEVEL; FEMALE; HOT FLUSH; HUMAN; LAPAROSCOPY; MOOD; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION;

EID: 0030979859     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599709152533     Document Type: Article

References (26)

1. Belchetz, P. E., Plant, T. M., Nakai, Y., Keogh, E. J. and Knobil, E. (1978). Hypophyseal responses to continuous and intermittent delivery of hypothalamic gonadotropin releasing hormone. Science, 202, 631
2. Meldrum, D. R., Chang, R. J., Lu, J., Vale, W., Rivier, J. and Judd, H. L. (1982). Medical oophorectomy using a long-acting GnRH agonist: a possible new approach to treatment of endometriosis. J. Clin. Endocrinol. Metab., 54, 1081-3
3. Barbieri, R. L. (1990). Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy. Am. J. Obstet. Gynecol., 162, 593-5
4. Saltiel, E. and Garabedian-Ruffalo, S. M. (1991). Pharmacologie management of endometriosis. Clin. Pharm., 10, 518-31
5. Dawood, M. Y. (1994). Hormonal therapies for endometriosis: implications for bone metabolism. Acta Obstet. Gynecol. Scand. Suppl., 159, 22-34
6. Jacobson, J., Harris, S. R. and Bullingham, E. S. (1994). Low dose intranasal nafarelin for the treatment of endometriosis. Acta Obstet. Gynecol. Scand., 73, 144-50
7. Edmonds, D. K. and Howell, R. (1994). Can hormone replacement therapy be used during medical therapy of endometriosis? Br. J. Obstet. Gynaecol., 101, Suppl. 10, 24-6
8. Friedman, A. J. and Hornstein, M. D. (1993). Gonadotropin-releasing hormone agonist plus estrogen-progestin 'add-back' therapy for endometriosis-related pelvic pain. Fertil. Steril., 60, 236-41
9. Leather, A. T., Studd, J. W. W., Watson, N. R. and Holland, E. F. N. (1993). The prevention of bone loss in young women treated with GnRH analogs with 'add-back' estrogen therapy. Obstet. Gynecol., 81, 104-7
10. Surrey, E. S. (1995). Steroidal and nonsteroidal 'add-back' therapy: extending safety and efficacy of gonadotropin-releasing hormone agonists in the gynecologic patient. Fertil. Steril., 64, 673-85
11. American Fertility Society (1985). Revised American Fertility Society classification of endometriosis. Fertil. Steril., 43, 351
12. Henzl, M. R., Corson, S. L., Moghissi, K., Buttram, V. C., Bergqvist, C. and Jacobson, J. (1988). Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial. N. Engl. J. Med., 318, 485-9
13. Kennedy, S. H., Williams, I. A., Brodribb, J., Barlow, D. H. and Shaw, R. W. (1990). A comparison of nafarelin acetate and danazol in the treatment of endometriosis. Fertil. Steril., 53, 998-1003
14. The Nafarelin European Endometriosis Trial (NEET) Groups (1992). Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up. Fertil. Steril., 57, 514-22
15. Adashi, E. Y. (1994). Long-term gonadotrophin-releasing hormone agonist therapy: the evolving issue of steroidal 'add-back' paradigm. Hum. Reprod., 9, 1380-97
16. Venturini, P. L., Fasce, V., Costantini, S., Anserini, P., Cucuccio, S. and De Cecco, L. (1990). Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results. Fertil. Steril., 54, 1021-7
17. Waller, K. G. and Shaw, R. W. (1993). Gonadotropin-releasing hormone analogs for the treatment of endometriosis: long-term follow-up. Fertil. Steril., 59, 511-14
18. Johansen, J. S., Riis, B. J., Hassager, C., Moen, M., Jacobsen, J. and Christiansen, C. (1988). The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism. J. Clin. Endocrinol. Metab., 67, 701-6
19. Ravn, P., Bergqvist, A., Hansen, M. A., Overgaard, K. and Christiansen, C. (1994). Treatment of endometriosis with the luteinizing hormone-releasing hormone agonist nafarelin. Effect on bone turnover and bone mass. Maturitas, 1, 11-17
20. Riis, B. J., Christiansen, C., Johansen, J. S. and Jacobsen, J. (1990). Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists? J. Clin. Endocrinol. Metab., 70, 920-40
21. Surrey, E. S., Gambone, J. C., Lu, J. K. H. and Judd, H. L. (1990). The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis. Fertil. Steril., 53, 620-6
22. Surrey, E. S. and Judd, H. L. (1992). Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. J. Clin. Endocrinol. Metab., 75, 558-63
23. Eldred, J. M., Haynes, P. J. and Thomas, E. J. (1992). A randomized double-blind placebo-controlled trial of the effects on bone metabolism of the combination of nafarelin acetate and norethisterone. Clin. Endocrinol., 37, 354-9
24. Monroe, S. E., Blumenfeld, Z., Andreyko, J. L., Schriock, E., Henzl, M. R. and Jaffrey, R. B. (1986). Dose-dependent inhibition of pituitary-ovarian function during administration of gonadotropin-releasing hormone agonist analog (nafarelin). J. Clin. Endocrinol. Metab., 63, 1334-41
25. Bergqvist, A., Landgren, B.-M. and Diczfalusy, E. (1988). A clinical, pharmacokinetic and pharmacodynamic study of three progestogens in the treatment of endometriosis. New Trends Obstet. Gynecol., 4, 65-84
26. Barbieri, R. L. (1992). Hormone treatment of endometriosis: the estrogen threshold hypothesis. Am. J. Obstet. Gynecol., 166, 740-5